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You have reviewed the data with the research fellow and
approved the final version of the manuscript. You are ready
to submit it for publication. Accordingly, you click “send”
on your computer screen and your manuscript may appear
almost immediately on the NIH-sponsored E-biomed and
will be available to the entire world through the Internet.
This is one aspect of the controversial E-biomed proposal of
Dr. Harold Varmus, Director of the National Institutes of
Health (1).
Two mechanisms for submission of manuscripts are
envisioned. The first option is more traditional and would
incorporate current editorial boards of scientific journals in
the usual way. Once a manuscript is accepted, it is posted
immediately on E-biomed and would be listed in the
current table of contents for that journal. If an article is
rejected and if the authors deem it difficult to publish
elsewhere, they may utilize a second option by directly
submitting it to E-biomed. It would then have to be
approved by two individuals before entering the data base.
Criteria for approval would “be sufficiently firm to guard
against gross abuse of the E-biomed repository, but suffi-
ciently flexible to permit rapid posting of virtually any
legitimate work” (1). It is then envisioned that such an
article already posted on the Internet could subsequently be
sent by the authors to an editorial board and receive
endorsement after review and revision.
There are several potential advantages of E-biomed:
widespread and rapid dissemination of scientific informa-
tion on the Internet, improved methods of presentation and
reduced cost to authors and readers.
The problems with the proposal, however, are consider-
able. First and foremost is the lack of real peer review for
option 2. Peer review can lead to rejection of manuscripts
that are based on poor science. By contrast, peer review can
markedly improve submissions before final acceptance. Be-
sides, almost all journals such as JACC have their manu-
scripts in full on their own website, accessible on the
Internet. One can envision E-biomed being flooded with
questionable reports that will only confuse and mislead
readers. This may be especially dangerous in the case of
clinical research that can cause changes in clinical practice
based on faulty science. I agree with Relman (2) that clinical
research is clearly different from basic research. Practicing
clinicians and the lay public may not be able to evaluate the
correctness of a clinical report and may adopt clinical
practices that are of no value whatsoever, or at the worst,
even harmful. I would envision that E-biomed may also
lend unintended authenticity to questionable medical alter-
natives because they are published in an authoritative data
base.
There are other troublesome problems with the proposal
that would be consequential:
c Societies and journals would lose their fiscal ability to
support the complex editorial and review process. How
would journals support the editorial staff without adver-
tising income from the printed page and membership
subscription fees?
c How would university promotion committees judge re-
search productivity from what might turn out to be many
minimally reviewed papers on E-biomed. Simply count-
ing the numbers of “publications” could be very mislead-
ing.
c How would the reader find his or her way through the
forest of reports on an individual topic and still be able to
judge the quality of each tree?
c Why would journals such as JACC want to review
material already on the Internet to validate it?
c It is unclear who would pay for and maintain such a
system. Would the federal government maintain a long-
term commitment to this enterprise? What happens when
funding diminishes?
The current publication process has served the scientific
community well. Almost all journals are either on the
Internet currently or have plans to be there. It is critical that
we not destroy the merits of the current process by a radical
proposal of mixed merit. The proposal needs a de novo
revision based on these and other reviewers’ comments.
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